Stonegate Capital Partners Initiates Coverage on Skin Enterprises Inc. with Positive Outlook
TL;DR
Skin Enterprises Inc. offers investors a competitive edge with its strong Q2 performance, strategic expansion into India, and the launch of the Prysm iO wellness device.
Skin Enterprises Inc. reported Q2 revenue of $386.1M and adj EPS of $0.43, with gross margin at 68.8%, driven by operational optimization and revenue growth.
Skin Enterprises Inc.'s expansion into India and the Prysm iO device aim to enhance global wellness, making personalized health recommendations accessible on a large scale.
Skin Enterprises Inc. surprises with a 103.5% year-over-year growth in Adj. Net Income and a strategic push into India, signaling robust future growth potential.
Found this article helpful?
Share it with your network and spread the knowledge!
Stonegate Capital Partners has recently initiated coverage on Skin Enterprises Inc. (NYSE: NUS), showcasing the company's robust financial results and its strategic initiatives aimed at fostering growth. Skin Enterprises reported revenue, adjusted Net Income, and adjusted EPS of $386.1M, $21.1M, and $0.43, respectively, with revenue at the high end of the guidance range. The Rhyz Manufacturing segment notably saw a 17% year-over-year revenue growth, and EPS significantly outpaced guidance. Gross margin for the quarter was 68.8%, reflecting a quarter-over-quarter expansion of 106 bps from 1Q25.
The company's strong performance is attributed to its focus on revenue growth and operational optimization, leading to a remarkable year-over-year growth of adjusted Net Income by 103.5%. Skin Enterprises is also making strides with two strategic initiatives: expansion into India and the launch of the Prysm iO wellness device. The India expansion is on track for pre-opening activities in 4Q25, with a full launch anticipated in mid-2026. The Prysm iO, an AI-powered wellness assessment device, is expected to revolutionize the company's approach to personalized product recommendations.
Despite a year-over-year decline in sales leaders, paid affiliates, and customers, Skin Enterprises has seen strong revenue growth in Latin America, thanks to its scalable digital-first model. The company ended the quarter with a solid balance sheet, including $264.2M in cash on hand, and has tightened its FY25 revenue guidance to $1.48B to $1.55B, while raising its adjusted EPS guidance to $1.15 to $1.35. Stonegate Capital Partners values Skin Enterprises at a forward Price to adjusted EPS of 5.2x, applying a valuation range that suggests significant upside potential.
For more information on Skin Enterprises Inc., visit https://www.nuskin.com. Stonegate Capital Partners' coverage provides a comprehensive analysis of Skin Enterprises' financial health and growth prospects, underscoring the company's potential in the evolving wellness and beauty industry.
Curated from Reportable
